We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01518998
First Posted: January 26, 2012
Last Update Posted: July 1, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Gachon University Gil Medical Center
The Catholic University of Korea
Kyungpook National University
Daegu Catholic University Medical Center
Wonkwang University Hospital
Wonju Severance Christian Hospital
Korea University Guro Hospital
DongGuk University
Yeungnam University Hospital
Chonnam National University Hospital
Cheil General Hospital and Women’s Healthcare Center
Chungnam National University
Asan Medical Center
Seoul National University Bundang Hospital
Inha University Hospital
Seoul National University Hospital
Inje University
Samsung Medical Center
Busan National University Yangsan Hospital
Soon Chun Hyang University
Catholic University of Korea Saint Paul's Hospital
Hallym University Kangnam Sacred Heart Hospital
Jeju National University Hospital
Hanyang University Seoul Hospital
Kangbuk Samsung Hospital
Information provided by (Responsible Party):
Boryung Pharmaceutical Co., Ltd